Proposed Collection; 60-Day Comment Request; Evaluation of Cancer Control Leadership Forums at the Center for Global Health, 41295-41296 [2014-16445]

Download as PDF 41295 Federal Register / Vol. 79, No. 135 / Tuesday, July 15, 2014 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued A.12.1 ESTIMATES OF HOUR BURDEN [Appendices 11, 14 and 15] Type of respondents Number of responses per respondent Number of respondents Survey instrument Average time per response (in hours) Total burden hours AFU Year 11 .................................... 16222 1 15/60 4055 Total ........................................... ........................................................... ........................ 120/60 30940 ........................ Physicians and/or other health care providers. Informants ......................................... Hospitalization records/physician interview (Appendix 16, PQE). Informant Interview Deaths (Appendix 16, IIE/IIS). 1591 1 30/60 796 154 1 30/60 77 Total ........................................... ........................................................... ........................ ........................ 60/60 873 Dated: June 18, 2014. Michael Lauer, Director, DCVS, NHLBI, NIH. Dated: June 18, 2014. Lynn Susulske, NHLBI Project Clearance Liaison, National Institutes of Health. [FR Doc. 2014–16528 Filed 7–14–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES Proposed Collection; 60-Day Comment Request; Evaluation of Cancer Control Leadership Forums at the Center for Global Health Summary: In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Cancer Institute (NCI), National Institutes of Health (NIH), will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, VerDate Mar<15>2010 17:46 Jul 14, 2014 Jkt 232001 including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. To Submit Comments And For Further Information: To obtain a copy of the data collection plans and instruments, or request more information on the proposed project, contact: Brenda Kostelecky, Center for Global Health, National Cancer Institute, 9609 Medical Center Dr., RM 3W276, Rockville MD, 20850 or call non-tollfree number 240–276–5585 or Email your request, including your address to: brenda.kostelecky@nih.gov. Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Evaluation of Cancer Control Leadership Forums at the Center for Global Health (CGH) (NCI), 0925–NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: This submission is a request for OMB to approve the Cancer Control Leadership Forums. These workshops are organized and funded by the National Cancer Institute’s CGH in PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 conjunction with various partners ranging from foreign Ministries of Health and research institutions, to international non-governmental organizations (NGOs) and U.S. academic institutions. The goal of the U.S. National Cancer Institute (NCI) Cancer Control Leadership Forums is to increase the capacity of participating countries to initiate or enhance cancer control planning and implementation in their respective countries. The Forums are an opportunity for countries to exchange experiences and ideas about creating and implementing comprehensive cancer control plans. The proposed evaluation requests information about the outcomes of the forums including (1) status of cancer control planning and implementation in each participating country, (2) outcomes related to the action plans (e.g. developing written materials, completion of action items, resources and support acquired),(3) successes and challenges related to the action plans, and (4) new cancer control partnerships and networks. Baseline information regarding the status of cancer control planning and implementation will be collected 3 months prior to the Forums in order to inform the development of each Forum. The evaluation information will be collected 3–24 months after each forum and is needed to evaluate the effectiveness of these workshops in order to inform future programming and funding decisions. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 108. E:\FR\FM\15JYN1.SGM 15JYN1 41296 Federal Register / Vol. 79, No. 135 / Tuesday, July 15, 2014 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name Chief Executives ........ 3 Months Pre Workshop Form ................................ 3 Months Post Workshop Form .............................. 6 Months Post Workshop Form .............................. 12 Months Post Workshop Form ............................ 24 Months Post Workshop Form ............................ Dated: July 3, 2014. Karla Bailey, NCI Project Clearance Liaison, National Institutes of Health. [FR Doc. 2014–16445 Filed 7–14–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings mstockstill on DSK4VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: AIDS and AIDS Related Research. Date: July 21, 2014. Time: 12:00 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Jose H. Guerrier, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301–435– 1137, guerriej@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Academic Research Enhancement Award. Date: July 22, 2014. Time: 1:00 p.m. to 4:00 p.m. VerDate Mar<15>2010 17:46 Jul 14, 2014 Jkt 232001 18 18 18 18 18 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Rebecca Henry, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3158, MSC 7770, Bethesda, MD 20892, 301–435– 1717, henryrr@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Aging: Skeletal and Cardiac Muscle. Date: July 23, 2014. Time: 1:00 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Samuel C. Edwards, Ph.D., IRG CHIEF, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5210, MSC 7846, Bethesda, MD 20892, (301) 435–1246, edwardss@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; EAE\Multiple Sclerosis Neuroimmunology. Date: July 31, 2014. Time: 1:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Samuel C. Edwards, Ph.D., IRG CHIEF, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5210, MSC 7846, Bethesda, MD 20892, (301) 435–1246, edwardss@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cell Biology, Development and Aging. Date: August 4–5, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 Number of responses per respondent 1 1 1 1 1 Average burden per response (in hours) Total annual burden hours 2 1 1 1 1 36 18 18 18 18 Contact Person: Elena Smirnova, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5187, MSC 7840, Bethesda, MD 20892, 301–435– 1236, smirnove@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Genetic Variation and Evolution Applications. Date: August 6, 2014. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Barbara J. Thomas, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2218, MSC 7890, Bethesda, MD 20892, 301–435– 0603, bthomas@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Adult Psychopathology and Disorders of Aging. Date: August 6, 2014. Time: 2:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Andrea B. Kelly, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD 20892, (301) 455– 1761, kellya2@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; AREA Grants: Genomics. Date: August 6, 2014. Time: 4:00 p.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Ronald Adkins, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2206, MSC 7890, Bethesda, MD 20892, 301–435– 4511, ronald.adkins@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR13– 309–311: Translational Research in Pediatric and Obstetric, Pharmacology and Therapeutics. E:\FR\FM\15JYN1.SGM 15JYN1

Agencies

[Federal Register Volume 79, Number 135 (Tuesday, July 15, 2014)]
[Notices]
[Pages 41295-41296]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-16445]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; 60-Day Comment Request; Evaluation of Cancer 
Control Leadership Forums at the Center for Global Health

    Summary: In compliance with the requirement of Section 
3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity 
for public comment on proposed data collection projects, the National 
Cancer Institute (NCI), National Institutes of Health (NIH), will 
publish periodic summaries of proposed projects to be submitted to the 
Office of Management and Budget (OMB) for review and approval.
    Written comments and/or suggestions from the public and affected 
agencies are invited on one or more of the following points: (1) 
Whether the proposed collection of information is necessary for the 
proper performance of the function of the agency, including whether the 
information will have practical utility; (2) The accuracy of the 
agency's estimate of the burden of the proposed collection of 
information, including the validity of the methodology and assumptions 
used; (3) Ways to enhance the quality, utility, and clarity of the 
information to be collected; and (4) Ways to minimize the burden of the 
collection of information on those who are to respond, including the 
use of appropriate automated, electronic, mechanical, or other 
technological collection techniques or other forms of information 
technology.
    To Submit Comments And For Further Information: To obtain a copy of 
the data collection plans and instruments, or request more information 
on the proposed project, contact: Brenda Kostelecky, Center for Global 
Health, National Cancer Institute, 9609 Medical Center Dr., RM 3W276, 
Rockville MD, 20850 or call non-toll-free number 240-276-5585 or Email 
your request, including your address to: brenda.kostelecky@nih.gov. 
Formal requests for additional plans and instruments must be requested 
in writing.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 60 days 
of the date of this publication.
    Proposed Collection: Evaluation of Cancer Control Leadership Forums 
at the Center for Global Health (CGH) (NCI), 0925-NEW, National Cancer 
Institute (NCI), National Institutes of Health (NIH).
    Need and Use of Information Collection: This submission is a 
request for OMB to approve the Cancer Control Leadership Forums. These 
workshops are organized and funded by the National Cancer Institute's 
CGH in conjunction with various partners ranging from foreign 
Ministries of Health and research institutions, to international non-
governmental organizations (NGOs) and U.S. academic institutions. The 
goal of the U.S. National Cancer Institute (NCI) Cancer Control 
Leadership Forums is to increase the capacity of participating 
countries to initiate or enhance cancer control planning and 
implementation in their respective countries. The Forums are an 
opportunity for countries to exchange experiences and ideas about 
creating and implementing comprehensive cancer control plans. The 
proposed evaluation requests information about the outcomes of the 
forums including (1) status of cancer control planning and 
implementation in each participating country, (2) outcomes related to 
the action plans (e.g. developing written materials, completion of 
action items, resources and support acquired),(3) successes and 
challenges related to the action plans, and (4) new cancer control 
partnerships and networks. Baseline information regarding the status of 
cancer control planning and implementation will be collected 3 months 
prior to the Forums in order to inform the development of each Forum. 
The evaluation information will be collected 3-24 months after each 
forum and is needed to evaluate the effectiveness of these workshops in 
order to inform future programming and funding decisions.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 108.

[[Page 41296]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total annual
     Type of respondents           Form name        respondents    responses per   response (in    burden hours
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Chief Executives.............  3 Months Pre                   18               1               2              36
                                Workshop Form.
                               3 Months Post                  18               1               1              18
                                Workshop Form.
                               6 Months Post                  18               1               1              18
                                Workshop Form.
                               12 Months Post                 18               1               1              18
                                Workshop Form.
                               24 Months Post                 18               1               1              18
                                Workshop Form.
----------------------------------------------------------------------------------------------------------------


    Dated: July 3, 2014.
Karla Bailey,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2014-16445 Filed 7-14-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.